Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management

Comprehensive molecular landscaping studies reveal a potentially brighter future for pancreatic ductal adenocarcinoma (PDAC) patients. Blood-borne biomarkers obtained from minimally invasive “liquid biopsies” are now being trialled for early disease detection and to track responses to therapy. Integ...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreyer, Daniel, Neoptolemos, John P., Barry, Simon T., Bailey, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793685/
https://www.ncbi.nlm.nih.gov/pubmed/35096825
http://dx.doi.org/10.3389/fcell.2021.795735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793685/
https://www.ncbi.nlm.nih.gov/pubmed/35096825
http://dx.doi.org/10.3389/fcell.2021.795735

Ejemplares similares